Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.
| Autor: | Singh MP; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, UP, 211004, India., Rai S; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, UP, 211004, India., Pandey A; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, UP, 211004, India., Singh NK; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, UP, 211004, India., Srivastava S; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, UP, 211004, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Genes & diseases [Genes Dis] 2019 Oct 30; Vol. 8 (2), pp. 133-145. Date of Electronic Publication: 2019 Oct 30 (Print Publication: 2021). |
| DOI: | 10.1016/j.gendis.2019.10.013 |
| Abstrakt: | Molecular subtypes-based therapies offer new potential framework for desired and precise outcome in clinical settings. Current treatment strategies in colorectal cancer are largely 'one drug fit all' model for patients that display same pathological conditions. However, CRC is a very heterogenous set of malignancy that does not support for above criteria. Each subtype displays different pathological and genetic signatures. Based on these features, therapeutic stratification for individual patients may be designed, which may ultimately lead to improved therapeutic outcomes. In this comprehensive review, we have attempted to briefly outline major CRC pathways. A detailed overview of molecular subtypes and their clinical significance has been discussed. Present and future methods, governing CRC subtyping in the era of personalized therapy with a special emphasis on CMS subtypes of CRC has been reviewed. Together, discovery and validation of new CRC patient stratification methods, screening for novel therapeutic targets, and enhanced diagnosis of CRC may improve the treatment outcome. (© 2019 Chongqing Medical University. Production and hosting by Elsevier B.V.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|